Concepedia

Mike Recher

MR

Statistics

Publications

84

Citations

6.8K

H-Index

40

Active since

2002

Affiliations

University Hospital of Basel(Current)

University Hospital of Zurich

Heinrich Heine University Düsseldorf

Harvard University

University of Zurich

Mike Recher is an author at University Hospital of Basel specializing in life sciences, immunology, and immunopathology.

ORCID

Publications per year

2002–2023

84

Publications

84

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich et al. · Journal of Allergy and Clinical Immunology · 2018 · 441 citations · Full text

, , +12

Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer

Fiamma Berner, David Bomze, Stefan Diem et al. · JAMA Oncology · 2019 · 393 citations · Full text

, , +17

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Karl S. Lang, Mike Recher, Tobias Junt et al. · Nature Medicine · 2005 · 373 citations · Full text

, , +16

Memory CD8 + T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function

Maria L. Balmer, H. Eric, Glenn R. Bantug et al. · Immunity · 2016 · 352 citations · Full text

, , +14

Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8 <sup>+</sup> T-cell immunity

Philipp A. Lang, Karl S. Lang, Haifeng C. Xu et al. · Proceedings of the National Academy of Sciences · 2011 · 313 citations

, , +17

1–5 of 84